Varian Medical Systems Inc (VAR)

104.63
2.35 2.20
NYSE : Health Care
Prev Close 106.98
Open 107.00
Day Low/High 104.43 / 107.49
52 Wk Low/High 75.20 / 107.87
Volume 668.29K
Avg Volume 765.10K
Exchange NYSE
Shares Outstanding 91.80M
Market Cap 9.75B
EPS 4.20
P/E Ratio 35.04
Div & Yield N.A. (N.A)

Latest News

The New #38 Most Shorted S&P 500 Component: Varian Medical Systems

The New #38 Most Shorted S&P 500 Component: Varian Medical Systems

The most recent short interest data has been released for the 08/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

First Patient Treated With Varian HyperArc High Definition Radiotherapy

First Patient Treated With Varian HyperArc High Definition Radiotherapy

Patient treated at cancer care center in Italy

Varian Eclipse Users Generate Highest Scoring Plans In International Treatment Plan Competition

Varian Eclipse Users Generate Highest Scoring Plans In International Treatment Plan Competition

Two highest scoring plans and 7 of the top 10 at the 2017 International Radiotherapy Plan Competition used Eclipse treatment planning software

Varian Medical Systems Receives FDA 510(k) Clearance For Halcyon Treatment System

Varian Medical Systems Receives FDA 510(k) Clearance For Halcyon Treatment System

New system now has 510(k) clearance and CE mark

Experts Present New Radiosurgery Techniques Using Varian Technology For Optimal Targeting Of Multiple Metastases

Researchers to highlight advances in radiosurgery at International Stereotactic Radiosurgery Society (ISRS)

Varian ProBeam Proton Therapy System Receives Shonin Approval

Advanced proton therapy systems from Varian now available to cancer centers in Japan

New Varian Cancer Treatment Platform Draws Large Crowds At ESTRO 36 Tradeshow

Unveiled on show floor, Halcyon simplifies and enhances image-guided volumetric IMRT

Varian Launches Game-Changing Treatment Platform To Answer The Global Cancer Challenge

Halcyon human-centered design revolutionizes clinical workflow; simplifies and enhances image-guided volumetric IMRT

PerkinElmer Takes Cautious Approach to M&A

PerkinElmer Takes Cautious Approach to M&A

Even though it has $1.5 billion of M&A capacity, PerkinElmer is unlikely to pursue a large bolt-on deal, according to Cantor Fitzgerald analyst Bryan Brokmeier.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ARES, ASH, AXTA, BLMN, CNTY, EVK, HCOM, JWN, OB, RUSHB, SEDG, SUN, VAR, WES Downgrades: CYBE, KIM Initiations: WBT Read on to get TheStreet Quant Ratings' detailed report:

TheStreet Quant Rating: B+ (Buy)